CCNE1 and PLK1 mediates resistance to palbociclib in HR+/HER2- metastatic breast cancer View External Link Categories Peer Reviewed Publications Topics: breast cancer CDK Clinical Trial HER metastatic breast cancer MBC OBP PEARL
Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer View External Link Categories Peer Reviewed Publications Topics: breast cancer CDK46 inhibitors HARMONIA clinical trial HER2 Intrinsic subtypes OBP PAM50 Predictive biomarkers Precision oncology